Craneware, the Scottish company providing software to the US healthcare sector, said positive momentum has continued into its new financial year.

Alongside the group’s direct sales efforts, the alliance with Microsoft is progressing well, adding significant sales pipeline growth as well as continuing to help drive innovation, it said in an update ahead of its AGM.

US healthcare providers remain focused on optimising their operational and financial performance, driving demand for the group’s solutions.

The group, led by chief executive Keith Neilson, continues to invest in R&D to strengthen its product set, leveraging its proprietary data assets to expand its offerings and launch new AI enabled applications.

It is benefiting from high levels of recurring revenue and strong cash generation and the board said it remains confident in the delivery of continued growth over the near term as the company trades in line with market expectations for the year.

As previously announced, David Kemp, senior non-executive director, will stand down at the AGM and Alistair Erskine will become senior independent director. Susan Nelson becomes chair of the audit committee and Jill Goldsmith will take over the role of company secretary.